The FDA granted orphan status to Celgene's sotatercept in the treatment of anemias associated with myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasms, according to a post to the FDA's website.
On paper, Mark Zuckerberg is Meta’s lowest-paid employee, with a $1 dollar salary and no bonus.
The key Federal Reserve inflation rate, the core PCE price index, reared up in Q1 as GDP grew at a slower pace.
Tesla's loss of $328.3 billion this year in stock value certainly hurts. But it's only the second-largest market value loss in the S&P 500.
Meta's AI reality check has dented hopes for a Big Tech revival for stocks, with a GDP update showing the US economy grew slower than expected in the first quarter.
This growth ETF has nicely outperformed the S&P 500 since its inception.
Dividend Kings are hard to come by, but these five stocks offer investors some great passive income opportunities.
With rising inflation, American consumers are increasingly turning to the Chinese e-commerce platform Temu for their shopping needs. With its enticing tagline “Shop like a billionaire,” Temu has captured 17% of the U.S. market share, posing a challenge to traditional American retailers such as Amazon.com Inc., Dollar Tree Inc. and Five Below Inc. The rise highlights the lucrative and disruptive nature of startups. Owned and operated by PDD Holdings Inc. (NASDAQ:PDD), Temu offers a wide range of
One of Capitol Hill's most-active stock traders is sending a company with well-defined competitive advantages -- that also happens to be on the verge of its first-ever stock split -- to the chopping block.
Its adjusted quarterly loss was worse than expected despite record operating revenue fueled by strong travel demand.
Microsoft, which overtook Apple as the world's most valuable company earlier this year, is looking to cement its AI market leadership.
